ArticleJournal for immunotherapy of cancer2020

Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy.

Vincenzo Montesarchio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.